CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −16,229 | $12.52 | $203K | 976,271 |
| 2024-06-13 | Gold Alexander M Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2024-06-13 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −39,961 | $12.74 | $509K | 992,500 |
| 2024-06-12 | Congleton Jon Chief Executive Officer | Sale 10b5-1 | −16,607 | $12.77 | $212K | 1,032,461 |
| 2024-06-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,349 | $1.08 | $7K | 89,729 |
| 2024-06-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,349 | 190,357 | ||
| 2024-06-11 | Levy Adam Scott CFO and Secretary | Sale 10b5-1 | −96,815 | $12.94 | $1.3M | 255,462 |
| 2024-06-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 83,380 |
| 2024-06-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 35,121 | ||
| 2024-05-22 | Slingsby Brian Taylor Director | Other disposition · Stock Option | −22,000 | 0 | ||
| 2024-05-22 | Slingsby Brian Taylor Director | Other acquisition · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | DiRocco Derek Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | SBLENDORIO GLENN Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | Karydas Daphne Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | Slingsby Brian Taylor Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-22 | Litzka Olivier Director | Grant or award · Stock Option | +22,000 | 22,000 | ||
| 2024-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,018 | $0.54 | $3K | 72,015 |
| 2024-05-13 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,348 | $1.08 | $7K | 78,363 |
Page 18 of 23 · 446 trades